4.5 Article

Design, synthesis, and cytotoxic evaluation of quinazoline derivatives bearing triazole-acetamides

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Multidisciplinary

New 1,2,3-Triazole-genipin Analogues and Their Anti-Alzheimer's Activity

Patamawadee Silalai et al.

Summary: The designed and synthesized 1,2,3-triazole-genipin analogues showed neuroprotective activity and inhibition of butyrylcholinesterase. They have the potential to be promising lead compounds as anti-Alzheimer's agents.

ACS OMEGA (2022)

Article Biochemistry & Molecular Biology

Design and synthesis of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro α-glucosidase inhibition, kinetic and docking studies

Mohammad Sadegh Asgari et al.

Summary: A novel series of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids were synthesized and evaluated for their inhibitory activity against yeast alpha-glucosidase, showing promising potential as potential drugs for the treatment of diabetes.

MOLECULAR DIVERSITY (2021)

Article Biochemistry & Molecular Biology

Quinazolin-4(3H)-one based agents bearing thiadiazole-urea: Synthesis and evaluation of anti-proliferative and antiangiogenic activity

Aram Faraji et al.

Summary: A series of new compounds containing thiazole-urea were designed, synthesized, and evaluated for their biological activities. Compound 9f showed moderate growth inhibitory effects on cancer cells and induced apoptosis in HUVEC cells. The reduction in cell proliferation may be achieved by inhibiting the phosphorylation of VEGFR-2.

BIOORGANIC CHEMISTRY (2021)

Review Chemistry, Medicinal

FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: Synthesis and clinical application

Shuai Wang et al.

Summary: Considerable progress has been achieved in the development of anticancer agents in recent decades, with pyrimidine-fused bicyclic heterocycles showing potential for clinical treatment. New anticancer agents have been produced from natural and synthetic sources, with a focus on improving therapeutic efficacy for various cancers.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Review Chemistry, Medicinal

Therapeutic progression of quinazolines as targeted chemotherapeutic agents

Ranju Bansal et al.

Summary: Cancer is a serious health issue with available chemotherapeutic drugs being highly toxic and lacking selectivity. Advances in science have illuminated molecular pathways responsible for cancer, leading to the development of targeted anticancer agents, such as quinazoline derivatives. These agents act by inhibiting various protein kinases and other molecular targets, offering new opportunities for more effective cancer treatment.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Microwave assisted one-pot synthesis, photophysical and physicochemical studies of novel biologically active heterocyclic Donor (D)-π-Acceptor (A) chromophore

Salman A. Khan et al.

Summary: A new chromophore AEDQ was synthesized and studied using synthesis and fluorescence spectroscopic techniques, showing strong interactions with surfactants and potential for determining CMC values, as well as exhibiting good antibacterial activity and drug development properties.

BIOORGANIC CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Synthesis, biological evaluation and molecular docking studies of novel 1,2,3-triazole-quinazolines as antiproliferative agents displaying ERK inhibitory activity

Paulo Sergio Goncalves Nunes et al.

Summary: ERK1/2 inhibitors are being explored for their potential to overcome resistance to RAF and MEK kinase inhibitors. A new 4-aminoquinazoline derivative, compound 25a, showed promising activity in BT-20 cells by inducing cell death through lactate dehydrogenase release and necrosis induction. The compound also led to cell cycle arrest and downregulation of key signaling pathways in breast cancer cells.

BIOORGANIC CHEMISTRY (2021)

Article Chemistry, Physical

Synthesis and evaluation of new 4(3H)-Quinazolinone derivatives as potential anticancer agents

Srikanth Gatadi et al.

JOURNAL OF MOLECULAR STRUCTURE (2020)

Article Biochemistry & Molecular Biology

Synthesis and evaluation of Quinoline-3-carbonitrile derivatives as potential antibacterial agents

Salman A. Khan et al.

BIOORGANIC CHEMISTRY (2019)

Article Biochemistry & Molecular Biology

Synthesis and biological evaluation of novel imidazopyrimidin-3-amines as anticancer agents

Mohammad Mahdavi et al.

CHEMICAL BIOLOGY & DRUG DESIGN (2017)

Article Chemistry, Medicinal

Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors

Ann-Gerd Thorsell et al.

JOURNAL OF MEDICINAL CHEMISTRY (2017)

Review Biochemistry & Molecular Biology

An insight into the therapeutic potential of quinazoline derivatives as anticancer agents

Shagufta et al.

MEDCHEMCOMM (2017)

Article Chemistry, Medicinal

Synthesis and anticancer activity of N-substituted 2-arylquinazolinones bearing trans-stilbene scaffold

Mohammad Mahdavi et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)

Review Chemistry, Medicinal

Quinazoline derivatives as anticancer drugs: a patent review (2011-present)

Severine Ravez et al.

EXPERT OPINION ON THERAPEUTIC PATENTS (2015)

Article Biochemistry & Molecular Biology

Design, synthesis, in vitro cytotoxic activity evaluation, and apoptosis-induction study of new 9(10H)-acridinone-1,2,3-triazoles

Maryam Mohammadi-Khanaposhtani et al.

MOLECULAR DIVERSITY (2015)

Review Medicine, General & Internal

An overview of targeted cancer therapy

Viswanadha Vijaya Padma

BIOMEDICINE-TAIWAN (2015)

Article Biochemistry & Molecular Biology

A quinazoline-derivative compound with PARP inhibitory effect suppresses hypertension-induced vascular alterations in spontaneously hypertensive rats

Klara Magyar et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)

Article Biochemistry & Molecular Biology

Design, synthesis, antimicrobial activity and anti-HIV activity evaluation of novel hybrid quinazoline-triazine derivatives

Rahul P. Modh et al.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2014)

Editorial Material Biotechnology & Applied Microbiology

Novel Medicines and Strategies in Cancer Treatment and Prevention

Chih-Hsin Tang et al.

BIOMED RESEARCH INTERNATIONAL (2014)

Article Chemistry, Organic

Synthesis and Biological Applications of Triazole Derivatives – A Review

S. Sathish Kumar et al.

MINI-REVIEWS IN ORGANIC CHEMISTRY (2013)

Article Chemistry, Medicinal

Discovery of AZD2932, a new Quinazoline Ether Inhibitor with high affinity for VEGFR-2 and PDGFR tyrosine kinases

Patrick A. Ple et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)

Article Chemistry, Medicinal

Design, synthesis and evaluation of clinafloxacin triazole hybrids as a new type of antibacterial and antifungal agents

Yan Wang et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)

Article Chemistry, Medicinal

1,2,3-Triazole tethered β-lactam-Chalcone bifunctional hybrids: Synthesis and anticancer evaluation

Pardeep Singh et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)

Review Chemistry, Medicinal

Quinazoline derivatives as potential anticancer agents: a patent review (2007-2010)

Giovanni Marzaro et al.

EXPERT OPINION ON THERAPEUTIC PATENTS (2012)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Article Chemistry, Medicinal

Antimicrobial study of newly synthesized 6-substituted indolo[1,2-c]quinazolines

Rondla Rohini et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)

Review Oncology

Beyond chemotherapy: targeted therapies in ovarian cancer

Timothy A. Yap et al.

NATURE REVIEWS CANCER (2009)

Article Chemistry, Medicinal

Synthesis, determination of the lipophilicity, anticancer and antimicrobial properties of some fused 1,2,4-triazole derivatives

Krzysztof Sztanke et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2008)

Review Medicine, General & Internal

Metastasis: recent discoveries and novel treatment strategies

Suzanne A. Eccles et al.

LANCET (2007)

Article Chemistry, Medicinal

Synthesis characterization and anticancer activity studies on some Mannich bases derived from 1,2,4-triazoles

BS Holla et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2003)